Cargando…
Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT)
Cancer patients have an increased risk of developing venous thromboembolic events. Anticoagulation management includes prophylactic or therapeutic doses of low molecular weight heparins (LMWHs) or direct oral anticoagulants (DOACs). However, the management of thrombosis in patients with cancer is co...
Autores principales: | Tsoukalas, Nikolaos, Brito-Dellan, Norman, Font, Carme, Butler, Taylor, Rojas-Hernandez, Cristhiam M., Butler, Thomas, Escalante, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512854/ https://www.ncbi.nlm.nih.gov/pubmed/35932318 http://dx.doi.org/10.1007/s00520-022-07235-8 |
Ejemplares similares
-
Thrombosis, cancer, and COVID-19
por: Brito-Dellan, Norman, et al.
Publicado: (2022) -
Correction to: Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer‑associated thrombosis (CAT)
Publicado: (2022) -
Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies
por: Font, Carme, et al.
Publicado: (2022) -
Pre-clinical drug-drug interactions (DDIs) of gefitinib with/without losartan and selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, and venlafaxine
por: Luong, Thu-Lan T., et al.
Publicado: (2022) -
Chronic Pain: How Challenging Are DDIs in the Analgesic Treatment of Inpatients with Multiple Chronic Conditions?
por: Siebenhuener, Klarissa, et al.
Publicado: (2017)